Mixed Berry Sore Throat Lozenges Lozenge
NDC Package 36800-836-18
Package Information
Mixed Berry Sore Throat Lozenges (benzocaine) lozenges is uses temporarily relieves these symptoms: occasional minor mouth irritation, sore mouth and sore throatcough due to minor throat and bronichial irritation as may occur with the common cold. This formulation utilizes a lozenge delivery system. Marketed by Topco Associates, this product is identified by NDC 36800-836 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 1039251 - dextromethorphan HBr 5 MG / benzocaine 7.5 MG Oral Lozenge
- RxCUI: 1039251 - benzocaine 7.5 MG / dextromethorphan hydrobromide 5 MG Oral Lozenge
Clinical Specifications
- Allergens - [CS]
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Increased Histamine Release - [PE] (Physiologic Effect)
- Sigma-1 Agonist - [EPC] (Established Pharmacologic Class)
- Sigma-1 Receptor Agonists - [MoA] (Mechanism of Action)
- Standardized Chemical Allergen - [EPC] (Established Pharmacologic Class)
- Uncompetitive N-methyl-D-aspartate Receptor Antagonist - [EPC] (Established Pharmacologic Class)
- Uncompetitive NMDA Receptor Antagonists - [MoA] (Mechanism of Action)
Regulatory & Marketing
Hierarchy Structure
- 36800 - Topco Associates
- 36800-836 - Mixed Berry Sore Throat Lozenges
- 36800-836-18 - 18 LOZENGE in 1 BLISTER PACK
- 36800-836 - Mixed Berry Sore Throat Lozenges
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 36800-836-18 identifies a specific commercial package of 18 lozenge in 1 blister pack of Mixed Berry Sore Throat Lozenges, a human over the counter drug labeled by Topco Associates. This lozenge is formulated for oral use and contains benzocaine; dextromethorphan hydrobromide as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Topco Associates on August 03, 2018. The current certification is valid through December 31, 2026.
How is this Topco Associates product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 36800083618. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.